Lipigon Pharmaceuticals AB (publ) (STO:LPGO)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0015
-0.0012 (-44.44%)
Inactive · Last trade price on May 18, 2026
Market Cap908.90K -94.7%
Revenue (ttm)n/a
Net Income-32.44M
EPS-0.08
Shares Out605.93M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume141,352,400
Average Volume23,874,900
Open0.0027
Previous Close0.0027
Day's Range0.0011 - 0.0027
52-Week Range0.0011 - 0.1935
Beta0.13
RSI34.65
Earnings DateMay 25, 2026

About STO:LPGO

Lipigon Pharmaceuticals AB (publ), a clinical-stage pharmaceutical company, develops drugs for lipid related diseases in Sweden. Its product pipeline consists of Lipisense project, which is in phase II for the treatment of severe hypertriglyceridemia disease; Dyslipidemia project, which is in preclinical trial to treat cardiovascular disease and severe hypertriglyceridemia; and CAP project, which is in preclinical trial to treat and prevent lung injury associated with community-acquired pneumonia. The company has a license agreement with Leader... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 7
Stock Exchange Nasdaq Stockholm
Ticker Symbol LPGO
Full Company Profile

Financial Performance

Financial Statements

News

Lipigon Pharmaceuticals AB Quarterly report: Q4 2025

Lipigon Pharmaceuticals AB has published its Q4 2025 quarterly earnings report on March 26, 2026.

2 months ago - Filings

Lipigon Pharmaceuticals AB Annual report: Q4 2025

Lipigon Pharmaceuticals AB has published its Q4 2025 annual report on March 26, 2026.

2 months ago - Filings

Lipigon Pharmaceuticals AB Press release: Study Result

Lipigon Pharmaceuticals AB issued a press release on December 4, 2025, disclosing material business information to investors.

5 months ago - Filings

Lipigon Pharmaceuticals AB Quarterly report: Q3 2025

Lipigon Pharmaceuticals AB has published its Q3 2025 quarterly earnings report on November 20, 2025.

6 months ago - Filings

Lipigon Pharmaceuticals AB Quarterly report: Q2 2025

Lipigon Pharmaceuticals AB has published its Q2 2025 quarterly earnings report on August 26, 2025.

9 months ago - Filings

Lipigon Pharmaceuticals AB Quarterly report: Q1 2025

Lipigon Pharmaceuticals AB has published its Q1 2025 quarterly earnings report on May 22, 2025.

1 year ago - Filings